Amber and Marcus Capone share what it was like to stand in the Oval Office on April 18, 2026, as President Trump signed a historic executive order on psychedelic-assisted therapy.

They answer the questions everyone has been asking since the news broke. How did you end up there? What was it actually like? And what does this executive order really do?

In this conversation, Amber and Marcus walk through the executive order itself, the inside story of how they got on the guest list, the moment Caroline Leavitt pulled Marcus from the crowd when his name was missing from the lineup, what President Trump and Secretary Kennedy were like in person, the Joe Rogan text that set the timeline in motion, and a tribute to Dr. Nolan Williams and the Stanford ibogaine study that changed everything.

The executive order directs the FDA to fast-track psychedelic therapies that have received Breakthrough Therapy designation, establishes a Right to Try pathway for eligible patients, commits $50 million in matching federal funds for state-level psychedelic research, expands VA clinical trial collaboration, and instructs the Attorney General to fast-track rescheduling after Phase 3 approval.

This is not legalization. It is regulated, clinician-guided access, moved through the system years faster than business as usual.

For veterans, military families, couples, first responders, and anyone navigating healing, growth, and reinvention.

Disclaimers: VETS employees, staff, volunteers, and Ambassadors are not practitioners; all psychedelic-assisted therapy treatment takes place at vetted, third-party facilities that are monitored by medical professionals. VETS does not advocate for decriminalization or legalization of psychedelic modalities, but rather the monitored, clinical use of psychedelic-assisted therapy.